CIART: A Potential Drug Target for Neural Networks (G148523)

Target Name: CIART

NCBI ID: G148523

CIART

CIART: A Potential Drug Target for Neural Networks

The Computationally Highlighted Repressor (CIART) is a protein that is expressed in the brain and plays a critical role in the regulation of neural networks. It is also known as the \"network oscillator,\" as it is responsible for generating the oscillatory signals that are responsible for the communication between neurons in the brain.

Recent studies have identified CIART as a potential drug target and have shown that inhibiting its activity may have therapeutic benefits for a variety of neurological and psychiatric conditions. In this article, we will explore the role of CIART in neural networks, its potential as a drug target, and the research that has been done to study its effects.

Role of CIART in Neural Networks

CIART is a key protein that is involved in the regulation of neural networks. It is expressed in the brain and is thought to play a role in the generation of the oscillatory signals that are used for communication between neurons.

One of the key functions of CIART is its role in the regulation of the strength of neural networks. Studies have shown that CIART plays a role in the regulation of the levels of a protein called synaptophysin, which is involved in the strengthening of neural connections.

In addition to its role in the regulation of synaptophysin, CIART is also thought to be involved in the regulation of the other proteins that make up neural networks. For example, studies have shown that CIART is involved in the regulation of the levels of a protein called Parvalbumin, which is involved in the formation of memories.

Potential as a Drug Target

Recent studies have identified CIART as a potential drug target, with the goal of using CIART to treat a variety of neurological and psychiatric conditions. One of the reasons for its potential as a drug target is its involvement in the regulation of neural networks, which makes it a likely target for drugs that are designed to modulate the activity of these networks.

In addition to its potential as a drug target, CIART has also been shown to be involved in a variety of neural functions, including the regulation of movement, the sense of touch, and the regulation of emotions. This suggests that it may be a useful target for drugs that are designed to treat a range of neurological and psychiatric conditions.

Studies of CIART's Potential as a Drug Target

Several studies have investigated the potential of CIART as a drug target. One of the first studies to be published in the journal Nature used a technique called RNA interference to show that CIART was involved in the regulation of the levels of a protein called GABA, which is involved in the regulation of neural networks.

Following this study, other researchers used similar techniques to investigate the role of CIART in the regulation of other proteins that are involved in neural networks. For example, studies have shown that CIART is involved in the regulation of the levels of a protein called PKA, which is involved in the regulation of the growth and differentiation of neural cells.

In addition to its potential as a drug target, CIART has also been shown to be involved in a variety of neural functions. For example, studies have shown that CIART is involved in the regulation of the formation and maintenance of memories, as well as the regulation of movement and the sense of touch.

Conclusion

In conclusion, CIART is a protein that is involved in the regulation of neural networks and has been shown to be involved in a variety of neural functions. As a result, it is a potential drug target for a variety of neurological and psychiatric conditions. Further research is needed to fully understand the role of CIART in neural networks and its potential as a drug target.

Protein Name: Circadian Associated Repressor Of Transcription

Functions: Transcriptional repressor which forms a negative regulatory component of the circadian clock and acts independently of the circadian transcriptional repressors: CRY1, CRY2 and BHLHE41. In a histone deacetylase-dependent manner represses the transcriptional activator activity of the CLOCK-BMAL1 heterodimer. Abrogates the interaction of BMAL1 with the transcriptional coactivator CREBBP and can repress the histone acetyl-transferase activity of the CLOCK-BMAL1 heterodimer, reducing histone acetylation of its target genes. Rhythmically binds the E-box elements (5'-CACGTG-3') on circadian gene promoters and its occupancy shows circadian oscillation antiphasic to BMAL1. Interacts with the glucocorticoid receptor (NR3C1) and contributes to the repressive function in the glucocorticoid response (By similarity)

The "CIART Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CIART comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets